Healthcare Sector Review: McKesson Loses to Cardinal Health, Corcept Prospects High
Leerink upgraded Corcept Therapeutics Inc. (NASDAQ:CORT) citing increased confidence in Korlym’s approval prospects ahead of the February 17 PDUFA date.
The shares closed at $3.40, up $0.28, or 8.97%, on the day. Its market capitalization is $286.39 million.
The shares closed at $75.97, down $1.48, or 1.91%, on the day. Its market capitalization is $18.66 billion.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.